C. P. Samira and R. S. Andrisa, “Efficacy and Safety of Imiquimod 5% as Primary Therapy in Management of Nodular Basal Cell Carcinoma of the Eyelid”, OI, vol. 42, no. 2, Feb. 2017, doi: 10.35749/journal.v42i2.80.